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Nosocomial fungal bloodstream infections (BSI) are increasing significantly in hospitalized patients
and Candida parapsilosis has emerged as an important pathogen responsible for numerous
outbreaks. The objective of this study was to evaluate C. parapsilosis sensu lato infection
scenarios, regarding species distribution and strain relatedness. One hundred isolates of C.
parapsilosis sensu lato derived from blood cultures and catheter tips were analysed by multiplex
microsatellite typing and by sequencing D1/D2 regions of the ribosomal DNA. Our results indicate
that 9.5% of patients presented infections due to C. parapsilosis and Candida orthopsilosis,
57.1% due to C. parapsilosis, 28.3% due to C. orthopsilosis and 4.8% due to Candida
metapsilosis. Eighty per cent of the C. parapsilosis BSIs were due to a single strain that was also
identified in the catheter, but in 10% of the cases C. parasilosis was identified in the catheter but
the BSI was due to C. orthopsilosis. There is a significant probability that C. parapsilosis isolates
collected from the same patient at more than 3 months interval are of different strains (P50.0179).
Moreover, several isolates were identified persistently in the same hospital, infecting six different
patients. The incidence of polyfungal BSI infections with C. parapsilosis and C. orthopsilosis is
reported herein for the first time, emphasizing the fact that the species identified in the catheter is
not always responsible for the BSI, thus impacting the treatment strategy. The observation that
strains can remain in the hospital environment for years highlights the possible existence of
reservoirs and reinforces the need for accurate genotyping tools, such as the markers used for
elucidating epidemiological associations and detecting outbreaks.
INTRODUCTION
The incidence of candidaemia continues to increase,
particularly in hospitalized patients. Due to the substantial
morbidity and mortality associated with these infections it
is clear that fungal diseases have emerged as important
public health problems (Pfaller & Diekema, 2007). While
Candida albicans remains the most common causative
agent of candidaemia, the incidence of Candida parapsilosis
has increased significantly, outranking C. albicans in some
studies, depending on the period and geographical area
(Aittakorpi et al., 2012; Lagrou et al., 2007; Lockhart et al.,
2012; Maganti et al., 2011; Nucci et al., 2013; Parmeland
et al., 2013; Tragiannidis et al., 2012; Wu et al., 2011; Xess
et al., 2007). Candidaemia risk factors include the use of
broad-spectrum antibiotics, cancer chemotherapy, immu-
nosuppressive agents and indwelling medical devices
(Tumbarello et al., 2007). Nosocomial fungaemia due to
C. parapsilosis is mainly associated with the presence of a
central venous catheter, and with the use of parenteral
nutrition (Barchiesi et al., 2004). Although the primary
reservoir in the hospital setting is unknown, C. parapsilosis
carriage on the skin of healthy individuals, particularly on
the hands of health care workers, and hospital envir-
onmental surfaces has been consistently observed (Lupetti
et al., 2002; Sabino et al., 2011; Vaz et al., 2011). Although
frequently associated with neonates and the use of
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Abbreviations: BSI, bloodstream infection; DP, discriminatory power;
HSE, Hospital dos Servidores do Estado; HUPE, Hospital Universita´rio
Pedro Ernesto; SAM, Hospital Samaritano.
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of the 28S rRNA gene sequence of the isolates described in this study
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parenteral nutrition (Dizbay et al., 2008), C. parapsilosis
has also been frequently identified in adult intensive care
units, surgery and internal medicine departments (Diab-
Elschahawi et al., 2012). The discrimination of C. para-
psilosis strains is fundamental not only for the rapid
identification of the strains involved in the infection but
also to clarify nosocomial cross-transmission and possible
routes of transmission in hospital settings (van Asbeck et al.,
2009). Since the description of a microsatellite multiplex
strategy for C. parapsilosis strain differentiation (Sabino
et al., 2010), this method has been applied in several studies
mainly regarding outbreaks (Diab-Elschahawi et al., 2012;
Romeo et al., 2013; Vaz et al., 2011) and is described as
the most discriminatory method for C. parapsilosis strain
differentiation. Herein, we used this method to genotype
presumed C. parapsilosis isolates involved in fungaemia
episodes from three hospitals in Brazil and to determine the
patterns of relatedness of the isolates, including the pair
identified in the bloodstream/catheter.
METHODS
Strains. During the period August 2002 to April 2006 at Hospital dos
Servidores do Estado (HSE), 76 strains were isolated from
42 patients and were identified as C. parapsilosis sensu lato. For
comparison, an additional 20 strains from Hospital Universita´rio
Pedro Ernesto (HUPE) isolated before the year 2000 were also
studied, although no patient’s information was available, as well as
four isolates from Hospital Samaritano (SAM). In total, 100 isolates
of C. parapsilosis sensu lato derived from blood cultures and catheter
tips from patients admitted at three different hospitals in Rio de
Janeiro, Brazil, between 1998 and 2006, were analysed (Table 1).
These isolates were stored in 40 % (v/v) glycerol at 280 uC at the
yeast stock collection of the Laborato´rio de Micologia do Instituto
Nacional de Infectologia (INI) da Fundac¸a˜o Oswaldo Cruz (Fiocruz),
Rio de Janeiro, Brazil.
Species identification. The isolates were phenotypically identified
as C. parapsilosis sensu lato at the hospital of origin using VITEK 2
and API 20 C AUX systems (bioMe´rieux) following the manufac-
turer’s instructions. Molecular identification at the species level was
performed by sequencing the D1/D2 region of the 28S rRNA gene
(Asadzadeh et al., 2009). Sequences were edited with the Sequencer
version 4.9 software package (Genes Codes Corporation), aligned
with MEGA version 4.0.2 software and compared by BLAST with
sequences available from NCBI GenBank.
Microsatellite multilocus PCR amplification and fragment size
determination. Isolates identified as C. parapsilosis were further
discriminated by multilocus microsatellite amplification. Cultures
were grown at 30 uC for 2 days on YPD agar plates. Cells for colony
PCR were prepared as described by Vaz et al. (2011). The primers,
PCR amplification conditions and the allele size determination by
GENESCAN (version 3.7) analysis after a run on an ABI PRISM 310
genetic analyser (Applied Biosystems) were as described previously
(Sabino et al., 2010) with some modifications as described by Vaz et al.
(2011), namely the redesign of one primer. Fragment sizes were
determined automatically using GENESCAN 3.5 analysis software. The
discriminatory power (DP) of the method was calculated as described
by Hunter & Gaston (1988).
Data analysis. A distance matrix was generated using the Cavalli-
Sforza & Edwards method (Cavalli-Sforza & Edwards, 1967) with
Populations software (version 1.2.28) and the dendrogram was
constructed by the unweighted pair group method in NTSYSpc
software (version 2.02; Applied Biostatistics). Categorical data were
analysed using Fisher’s exact test, unless stated in the text. Results were
considered statistically significant when P-values were lower than 0.05.
RESULTS
Identification of C. parapsilosis sensu lato
isolates and epidemiology
A total of 100 isolates from C. parapsilosis sensu lato
fungaemia were analysed in this study. The majority of the
isolates were derived from the HSE (76 %) while 20 % were
derived from the HUPE and only 4 % from the SAM.
Isolates included 83 from blood cultures and 17 from
catheter tips (Table 1). Genotyping isolates with the micro-
satellite multiplex failed to amplify all markers in 39 isolates.
Since this multiplex strategy is specific to C. parapsilosis
sensu stricto (Sabino et al., 2010), all the isolates were
sequenced. Sequencing showed that 37 strains were Candida
orthopsilosis, two were Candida metapsilosis and the
remaining 61 were C. parapsilosis (Table 1). All sequences
showed 100 % identity. The majority of the C. orthopsilosis
isolates (29 isolates) derived from the HSE, while the eight
isolates remaining were obtained from patients attending
the HUPE. These isolates were obtained from 19 adult
patients and seven children. All C. metapsilosis isolates were
identified in patients from the HSE. Thus, considering all
isolates, 61 % were C. parapsilosis, 37 % were C. orthopsilosis
and 2 % were C. metapsilosis.
Considering only the isolates from the HSE, we determined
that 57.1 % (24 from 42) of patients presented fungaemia
due to C. parapsilosis, 28.6 % (12 from 42) due to C.
orthopsilosis and 4.8 % (2 from 42) due to C. metapsilosis.
Curiously, in the HSE C. parapsilosis and C. orthopsilosis
were isolated from the same patient in 9.5 % (4 from 42) of
patients. All cases of polyfungal infection were observed in
male patients, but no significant difference (P.0.05) in
species distribution was observed between the two sexes.
Three of these polyfungal infections occurred in children
and one in an adult patient. Likewise, no signifi-
cant difference was observed (P.0.05) regarding species
isolation considering the different years of isolation (from
August 2002 to April 2006). It was not possible to perform
these analyses with isolates from the HUPE since patient
information was incomplete. All patients under 18 years old
(nine children) were from the HUPE and 78 % were infected
with C. orthopsilosis (Table 1).
Microsatellite multiplex genotyping of
C. parapsilosis isolates
Genotyping of all C. parapsilosis sensu stricto isolates with
the microsatellite markers identified 39 multilocus geno-
types of which 24 were observed only once (Table 1). The
most prevalent genotype, MG1, was found in five isolates
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Table 1. Characterization of all isolates analysed in this study
Patient
no.
Isolate Hospital Origin Gender Age
classification
Collection
date
Species
identification
GenBank
accession no.
Microsatellite fragment (bp) MG Dendrogram
code
CP1 CP4a CP6 B
all1 : all2 all1 : all2 all1 : all2 all1 : all2
1 072 HSE Blood M Adult 13/1/2003 C. orthopsilosis KJ817137 NA NA NA NA – –
074 HSE Blood 13/1/2003 C. orthopsilosis KJ817139 NA NA NA NA – –
075 HSE Blood 9/2/2004 C. orthopsilosis KJ817140 NA NA NA NA – –
2 095 HSE Blood F 29/10/2005 C. parapsilosis KJ817160 219 : 261 251 : 251 252 : 288 147 : 149 MG-6 095HSEb02
3 088 HSE Blood F Adult 10/1/2005 C. parapsilosis KJ817153 237 : 243 299 : 299 297 : 327 129 : 129 MG-9 088HSEb03
4 083 HSE Blood M Adult 9/6/2004 C. parapsilosis KJ817148 240 : 243 NA 273 : 303 127 : 139 MG-16 083HSEb04
084 HSE Blood 1/7/2004 C. parapsilosis KJ817149 240 : 243 NA 273 : 303 127 : 139 MG-16 084HSEb04
5 001 HSE Blood F Adult 19/12/2002 C. parapsilosis KJ817066 189 : 240 236 : 236 315 : 315 165 : 167 MG-1 001HSEb05
002 HSE Blood 19/12/2002 C. parapsilosis KJ817067 189 : 240 236 : 236 315 : 315 165 : 167 MG-2 002HSEb05
6 013 HSE Catheter F Adult 6/11/2002 C. parapsilosis KJ817078 189 : 240 236 : 236 315 : 315 165 : 167 MG-1 013HSEc06
057 HSE Blood 28/10/2002 C. parapsilosis KJ817122 189 : 240 236 : 236 315 : 315 165 : 167 MG-1 057HSEb06
058 HSE Blood 6/11/2002 C. parapsilosis KJ817123 189 : 240 236 : 236 315 : 315 165 : 167 MG-1 058HSEb06
7 089 HSE Blood M Adult 10/1/2005 C. orthopsilosis KJ817154 NA NA NA NA – –
8 012 HSE Catheter M Adult 11/9/2002 C. parapsilosis KJ817077 240 : 240 239 : 239 294 : 294 121 : 121 MG-12 012HSEc08
9 078 HSE Blood M Child 5/5/2004 C. orthopsilosis KJ817143 NA NA NA NA – –
079 HSE Blood 6/5/2004 C. orthopsilosis KJ817144 NA NA NA NA – –
10 077 HSE Blood M Child 9/3/2004 C. parapsilosis KJ817142 243 : 243 236 : 236 300 : 300 111 : 111 MG-28 077HSEb10
11 027 HSE Catheter M Child 29/10/2005 C. parapsilosis KJ817092 243 : 261 242 : 242 354 : 360 129 : 129 MG-37 027HSEc11
096 HSE Blood 21/11/2005 C. orthopsilosis KJ817161 NA NA NA NA – –
097 HSE Blood 5/12/2005 C. orthopsilosis KJ817162 NA NA NA NA – –
098 HSE Blood 1/2/2006 C. parapsilosis KJ817163 240 : 240 236 : 236 264 : 267 145 : 145 MG-10 098HSEb11
12 006 HSE Blood M Child 14/4/2003 C. orthopsilosis KJ817071 NA NA NA NA – –
017 HSE Catheter 14/4/2003 C. orthopsilosis KJ817082 NA NA NA NA – –
13 024 HSE Catheter M Child 8/8/2005 C. parapsilosis KJ817089 243 : 246 299 : 302 285 : 291 127 : 129 MG-35 024HSEc13
092 HSE Blood 8/8/2005 C. orthopsilosis KJ817157 NA NA NA NA – –
093 HSE Blood 23/8/2005 C. parapsilosis KJ817158 243 : 246 299 : 302 285 : 291 127 : 129 MG-35 093HSEb13
14 023 HSE Catheter M Child 28/7/2005 C. parapsilosis KJ817088 240 : 240 236 : 236 264 : 267 145 : 145 MG-10 023HSEc14
091 HSE Blood 28/7/2005 C. orthopsilosis KJ817156 NA NA NA NA – –
15 010 HSE Blood M Child 1/2/2006 C. parapsilosis KJ817075 240 : 243 332 : 341 270 : 303 127 : 139 MG-23 010HSEb15
011 HSE Blood 1/2/2006 C. parapsilosis KJ817076 240 : 243 332 : 341 270 : 303 127 : 139 MG-23 011HSEb15
16 056 HSE Blood M Child 29/8/2002 C. orthopsilosis KJ817121 NA NA NA NA – –
17 018 HSE Catheter M Child 2/1/2004 C. orthopsilosis KJ817083 NA NA NA NA – –
067 HSE Blood 26/12/2003 C. orthopsilosis KJ817132 NA NA NA NA – –
068 HSE Blood 11/2/2004 C. orthopsilosis KJ817133 NA NA NA NA – –
071 HSE Blood 2/1/2004 C. orthopsilosis KJ817136 NA NA NA NA – –
18 020 HSE Catheter M Child 12/8/2004 C. parapsilosis KJ817085 243 : 243 236 : 236 291 : 294 131 : 131 MG-27 020HSEc18
085 HSE Blood 26/7/2004 C. parapsilosis KJ817150 243 : 243 236 : 236 291 : 294 131 : 131 MG-27 085HSEb18
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Table 1. cont.
Patient
no.
Isolate Hospital Origin Gender Age
classification
Collection
date
Species
identification
GenBank
accession no.
Microsatellite fragment (bp) MG Dendrogram
code
CP1 CP4a CP6 B
all1 : all2 all1 : all2 all1 : all2 all1 : all2
19 025 HSE Catheter M Adult 23/8/2004 C. parapsilosis KJ817090 240 : 243 332 : 341 270 : 303 127 : 139 MG-23 025HSEc19
094 HSE Blood 23/8/2005 C. orthopsilosis KJ817159 NA NA NA NA – –
20 021 HSE Catheter F Adult 12/8/2004 C. parapsilosis KJ817086 207 : 240 239 : 239 312 : 312 129 : 131 MG-4 021HSEc20
21 029 SAM Blood M Adult 6/9/2005 C. parapsilosis KJ817094 207 : 240 236 : 236 282 : 282 131 : 133 MG-3 029SAMb21
22 065 HSE Blood M Adult 10/11/2003 C. orthopsilosis KJ817130 NA NA NA NA – –
23 087 HSE Blood M Adult 24/9/2004 C. orthopsilosis KJ817152 NA NA NA NA – –
24 064 HSE Blood F Adult 17/6/2003 C. metapsilosis KJ817129 NA NA NA NA – –
25 059 HSE Blood F Adult 3/2/2003 C. orthopsilosis KJ817124 NA NA NA NA – –
26 099 HSE Blood F Adult 3/4/2006 C. parapsilosis KJ817164 243 : 243 296 : 296 264 : 324 129 : 157 MG-31 099HSEb26
27 003 HSE Blood M Adult 20/2/2003 C. parapsilosis KJ817068 243 : 243 299 : 299 264 : 342 129 : 157 MG-32 003HSEb27
014 HSE Catheter 20/2/2003 C. parapsilosis KJ817079 243 : 243 299 : 299 264 : 342 129 : 157 MG-32 014HSEc27
054 HSE Blood 29/8/2002 C. parapsilosis KJ817119 240 : 240 272 : 272 273 : 273 103 : 103 MG-14 054HSEb27
055 HSE Blood 29/8/2002 C. parapsilosis KJ817120 240 : 240 272 : 272 273 : 273 103 : 103 MG-14 055HSEb27
28 080 HSE Blood M Adult 20/5/2004 C. parapsilosis KJ817145 240 : 243 NA 267 : 270 143 : 145 MG-15 080HSEb28
29 061 HSE Blood M Adult 28/2/2003 C. parapsilosis KJ817126 240 : 243 269 : 302 270 : 303 127 : 127 MG-20 061HSEb29
063 HSE Blood 12/5/2003 C. parapsilosis KJ817128 243 : 243 236 : 236 273 : 291 131 : 131 MG-26 063HSEb29
30 032 SAM Blood F Adult 7/10/2005 C. parapsilosis KJ817097 207 : 240 236 : 236 276 : 282 131 : 133 MG-2 032SAMb30
31 066 HSE Blood F Adult 14/11/2003 C. orthopsilosis KJ817131 NA NA NA NA – –
32 009 HSE Blood F Adult 1/2/2006 C. parapsilosis KJ817074 240 : 243 332 : 332 270 : 303 127 : 139 MG-22 009HSEb32
33 019 HSE Catheter F Adult 27/2/2004 C. parapsilosis KJ817084 240 : 240 239 : 239 279 : 312 109 : 109 MG-11 019HSEc33
076 HSE Blood 27/2/2004 C. parapsilosis KJ817141 240 : 240 239 : 239 294 : 312 109 : 109 MG-13 076HSEb33
34 081 HSE Blood F Adult 2/6/2004 C. parapsilosis KJ817146 243 : 243 290 : 290 291 : 291 131 : 131 MG-30 081HSEb34
35 004 HSE Blood M Adult 20/2/2003 C. orthopsilosis KJ817069 NA NA NA NA – –
016 HSE Catheter 28/2/2003 C. orthopsilosis KJ817081 NA NA NA NA – –
060 HSE Blood 20/2/2003 C. orthopsilosis KJ817125 NA NA NA NA – –
062 HSE Blood 28/2/2003 C. orthopsilosis KJ817127 NA NA NA NA – –
36 005 HSE Blood M Adult 28/2/2003 C. parapsilosis KJ817070 243 : 243 365 : 365 210 : 306 129 : 129 MG-34 005HSEb36
015 HSE Catheter 28/2/2003 C. parapsilosis KJ817080 243 : 243 365 : 365 210 : 306 129 : 129 MG-34 015HSEc36
37 082 HSE Blood F Adult 3/6/2004 C. parapsilosis KJ817147 264 : 264 236 : 236 273 : 273 143 : 143 MG-39 082HSEb37
38 100 HSE Blood M Adult 29/10/2005 C. parapsilosis KJ817165 207 : 240 281 : 311 282 : 312 133 : 133 MG-5 100HSEb38
39 007 HSE Blood F Adult 29/9/2005 C. parapsilosis KJ817072 234 : 243 287 : 296 297 : 297 131 : 131 MG-8 007HSEb39
008 HSE Blood 29/9/2005 C. parapsilosis KJ817073 234 : 243 287 : 296 297 : 297 131 : 131 MG-8 008HSEb39
026 HSE Catheter 29/9/2005 C. parapsilosis KJ817091 234 : 243 287 : 290 297 : 297 131 : 131 MG-7 026HSEc39
40 028 HSE Blood F Adult 19/12/2002 C. metapsilosis KJ817093 NA NA NA NA – –
41 022 HSE Catheter F Adult 24/9/2004 C. parapsilosis KJ817087 240 : 243 341 : 341 270 : 303 127 : 139 MG-24 022HSEc41
42 030 SAM Blood M Adult 6/9/2005 C. parapsilosis KJ817095 240 : 243 329 : 329 270 : 303 127 : 139 MG-21 030SAMb42
031 SAM Catheter 6/9/2005 C. parapsilosis KJ817096 240 : 243 332 : 332 270 : 303 127 : 139 MG-22 031SAMc42
43 053 HSE Blood M Adult 29/8/2002 C. orthopsilosis KJ817118 NA NA NA NA – –
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Table 1. cont.
Patient
no.
Isolate Hospital Origin Gender Age
classification
Collection
date
Species
identification
GenBank
accession no.
Microsatellite fragment (bp) MG Dendrogram
code
CP1 CP4a CP6 B
all1 : all2 all1 : all2 all1 : all2 all1 : all2
44 069 HSE Blood M Adult 29/12/2003 C. parapsilosis KJ817134 243 : 243 251 : 251 252 : 252 145 : 161 MG-29 069HSEb44
070 HSE Blood 30/12/2003 C. parapsilosis KJ817135 243 : 243 251 : 251 252 : 252 145 : 161 MG-29 070HSEb44
073 HSE Blood 13/1/2004 C. parapsilosis KJ817138 243 : 243 251 : 251 252 : 252 145 : 161 MG-29 073HSEb44
– 086 HSE Blood – Adult – C. orthopsilosis KJ817151 NA NA NA NA – –
– 090 HSE Blood – Adult – C. orthopsilosis KJ817155 NA NA NA NA – –
– 033 HUPE Blood – Adult –/–/1998 C. orthopsilosis KJ817098 NA NA NA NA – –
– 034 HUPE Blood – Adult 2/9/1999 C. orthopsilosis KJ817099 NA NA NA NA – –
– 035 HUPE Blood – Adult –/–/1998 C. parapsilosis KJ817100 246 : 246 299 : 299 243 : 303 129 : 147 MG-38 035HUPb00
– 036 HUPE Blood – Adult –/–/1998 C. orthopsilosis KJ817101 NA NA NA NA – –
– 037 HUPE Blood – Adult –/–/1998 C. orthopsilosis KJ817102 NA NA NA NA – –
– 038 HUPE Blood – Adult –/–/1998 C. parapsilosis KJ817103 240 : 243 245 : 272 273 : 273 133 : 133 MG-19 038HUPb00
– 039 HUPE Blood – Adult 23/9/1999 C. parapsilosis KJ817104 240 : 243 233 : 233 255 : 255 127 : 127 MG-17 039HUPb00
– 040 HUPE Blood – Adult 23/9/1999 C. parapsilosis KJ817105 240 : 243 233 : 254 255 : 255 127 : 127 MG-18 040HUPb00
– 041 HUPE Blood – Adult 2/9/1999 C. parapsilosis KJ817106 240 : 243 233 : 254 255 : 255 127 : 127 MG-18 041HUPb00
– 042 HUPE Blood – Adult 23/9/1999 C. parapsilosis KJ817107 243 : 249 299 : 302 288 : 303 105 : 127 MG-36 042HUPb00
– 043 HUPE Blood – Adult 2/9/1999 C. parapsilosis KJ817108 243 : 249 299 : 302 288 : 303 105 : 127 MG-36 043HUPb00
– 044 HUPE Blood – Adult 2/9/1999 C. parapsilosis KJ817109 243 : 243 329 : 329 285 : 306 129 : 129 MG-33 044HUPb00
– 045 HUPE Blood – Adult –/–/1998 C. orthopsilosis KJ817110 NA NA NA NA – –
– 046 HUPE Blood – Adult –/–/1998 C. orthopsilosis KJ817111 NA NA NA NA – –
– 047 HUPE Blood – Adult –/–/1998 C. orthopsilosis KJ817112 NA NA NA NA – –
– 048 HUPE Blood – Adult –/–/1998 C. parapsilosis KJ817113 243 : 243 212 : 236 303 : 303 111 : 111 MG-25 048HUPb00
– 049 HUPE Blood – Adult –/–/1998 C. parapsilosis KJ817114 243 : 243 212 : 236 303 : 303 111 : 111 MG-25 049HUPb00
– 050 HUPE Blood – Adult –/–/1998 C. parapsilosis KJ817115 243 : 243 212 : 236 303 : 303 111 : 111 MG-25 050HUPb00
– 051 HUPE Blood – Adult –/–/1998 C. parapsilosis KJ817116 243 : 243 212 : 236 303 : 303 111 : 111 MG-25 051HUPb00
– 052 HUPE Blood – Adult –/–/1998 C. orthopsilosis KJ817117 NA NA NA NA – –
–, No information available; all1, allele 1; all2, allele 2; MG, multilocus genotype; NA, no amplification; adult, .18 years old; child, ,18 years old.
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and was retrieved from two patients. Considering only
independent isolates (the first C. parapsilosis strain isolated
from each patient), the combined DP of the multiplex was
0.99, which is in agreement with previous studies (Diab-
Elschahawi et al., 2012; Sabino et al., 2010). In this study,
isolates with the same allelic combination at all micro-
satellite markers correspond to genetically similar strains
and were defined as identical, while isolates with distinct
allelic combinations at more than one locus correspond to
genetically dissimilar strains and were considered different
strains. The remaining cases, with minor changes in only
one locus, were considered as micro-variations.
In order to analyse strain relatedness, the multiple isolates
collected from the same patient were grouped (Table 2).
First, we observed that 12 of these patients were infected
exclusively with C. parapsilosis, five with C. orthopsilosis
and four with both C. parapsilosis and C. orthopsilosis.
These two species were isolated on the same day in all four
patients except patient 11, so the majority of these infec-
tions may be considered polyfungic. Curiously, in patients
infected only with C. orthopsilosis (patients 12, 17 and 35),
this species was also isolated from the catheter; however,
when C. parapsilosis was also present (patients 11, 13, 14
and 19) the species isolated from the catheter was always
C. parapsilosis.
Analysing C. parapsilosis strain relatedness from patients
with catheter and blood cultures isolates, we observed that
five patients showed identical bloodstream and catheter
strains (patients 6, 13, 18, 27 and 36), three showed micro-
variations in the pair bloodstream/catheter strains (patients
33, 39 and 42) and two presented different strains (patients
11 and 27). If the identical and microvariant cases are
grouped, 80 % of C. parapsilosis bloodstream/catheter pairs
showed similar strains. Indeed, there is a statistical pro-
bability (x254.00, P50.04) that the strain observed in the
catheter will also be present in the blood culture. However,
when Yates’ correction was applied this association was no
longer significant (x251.78, P50.18). Although the cases of
microvariation observed in this study were associated with
the presence of a catheter, the isolation dates were the same
so it was impossible to determine whether microvariation
occurred in the catheter strain.
Regarding the relatedness of C. parapsilosis strains isolated at
different collection dates, regardless of the presence or
absence of a catheter in patients that maintained the infecting
strain (patients 4, 6, 13, 18 and 44), the collection dates were
always within 1 month (Table 2). On the contrary, in all
cases in which a strain replacement was observed (patients
11, 27 and 29) the collection dates were always greater than
3 months. We observed that the probability of strain
replacement within 3 to 6 months was statistically signifi-
cant (P50.0179), suggesting that in these infections C.
parapsilosis strains were mainly acquired from the envir-
onment. One example was patient 11: a C. parapsilosis-
positive catheter culture was collected on day 1 with no
positive blood culture, in the following 2-month period two
blood cultures were positive for C. orthopsilosis and a third
blood culture was positive for a completely different C.
parapsilosis strain; these two C. parapsilosis strains were
collected 3 months apart. The presence of C. orthopsilosis
(patients 11 and 13), did not affect this correlation.
Clustering of C. parapsilosis isolates
When strains were compared regardless of their origin, we
observed that different patients shared similar strains (Fig.
1). Patient 6 presented a positive blood culture with isolate
057 and one month later the same strain was present in the
catheter and again in the blood (Table 1). More than a
month after this episode, patient 5, from the same hospital,
was infected with a similar strain (001). Other patients
from the same hospital, patients 14 and 11, also presented
strains with the same multilocus genotype (MG-10),
collected approximately 7 months apart (023 and 098).
Similarly, patients 19 and 15 from the same hospital shared
strains with MG-23 (010 and 025), collected almost
18 months apart (23 August 2004 and 1 February 2006).
Curiously, patients 42 and 32, from different hospitals, also
showed strains with the same multilocus genotype (MG-22;
isolates 009 and 031) collected 5 months apart (6
September 2005 and 1 Febuary 2006). Interestingly, MG-
22 and MG-23 differ only at locus CP4a and are considered
microvariants. In addition, MG-24 observed in isolate 022
from patient 41 and MG-21 in isolate 030 from patient 42
may also be considered microvariants of MG-22 and MG-
23 (Table 1). These observations suggest that isolates with
multilocus genotypes similar to isolate 25 (MG-23), the
first to be isolated, have been persistently isolated in
hospital settings over the period August 2004 to February
2006, affecting six different patients (Fig. 1). Similar cases
of micro-variation in different patients from the same
hospital were observed: isolate 029 from patient 21 (MG-3)
and one month later in isolate 032 from patient 30 (MG-2),
and isolate 062 from patient 29 (MG-26) and 14 months
later the microvariant MG-27 in isolate 085 from patient
18. Considering that the patients in this study are not
related, we cannot exclude the hypothesis of cross-
contamination of patients by the hands of healthcare
personnel, as extensively reported in other studies (Lupetti
et al., 2002; Vaz et al., 2011). Isolates 039 and 040 or 041
are also considered microvariants. However, due to the
lack of information regarding patients’ identity these may
not be considered as possible cross-contaminants.
DISCUSSION
The incidence of Candida in bloodstream infections has
been reported to be higher in Brazil than in the USA or
Europe, where C. parapsilosis has now become, respect-
ively, the second and third most common aetiological
agent of these infections after C. albicans (Colombo et al.,
1999; Dizbay et al., 2008; Hajjeh et al., 2004). However,
more recently some European regions, including southern
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Table 2. Genotypes obtained with microsatellites CP1, CP4a, CP6 and B in C. parapsilosis isolates from blood cultures and
catheters
Patient Hospital Origin Collection date MG or species identified C. parapsilosis multilocus genotype (bp)
CP1, CP4a, CP6 and B (all1 : all2)
Patient with catheter and bloodstream isolates
6 HSE Blood 28/10/2002 MG-1 189 : 240 236 : 236 315 : 315 165 : 167
Catheter 06/11/2002 MG-1 189 : 240 236 : 236 315 : 315 165 : 167
Blood 06/11/2002 MG-1 189 : 240 236 : 236 315 : 315 165 : 167
11 HSE Catheter 29/10/2005 MG-37 243 : 261 242 : 242 354 : 360 129 : 129
Blood 21/11/2005 C. orthopsilosis ND
Blood 05/12/2005 C. orthopsilosis ND
Blood 01/02/2006 MG-10 240 : 240 236 : 236 264 : 267 145 : 145
12 HSE Catheter 14/04/2003 C. orthopsilosis ND
Blood 14/04/2003 C. orthopsilosis ND
13 HSE Catheter 08/08/2005 MG-35 243 : 246 299 : 302 285 : 291 127 : 129
Blood 08/08/2005 C. orthopsilosis ND
Blood 23/08/2005 MG-35 243 : 246 299 : 302 285 : 291 127 : 129
14 HSE Catheter 28/07/2005 MG-10 240 : 240 236 : 236 264 : 267 145 : 145
Blood 28/07/2005 C. orthopsilosis ND
17 HSE Blood 26/12/2003 C. orthopsilosis ND
Catheter 02/01/2004 C. orthopsilosis ND
Blood 02/01/2004 C. orthopsilosis ND
Blood 11/02/2004 C. orthopsilosis ND
18 HSE Blood 26/07/2004 MG-27 243 : 243 236 : 236 291 : 294 131 : 131
Catheter 12/08/2004 MG-27 243 : 243 236 : 236 291 : 294 131 : 131
19 HSE Catheter 23/08/2004 MG-23 240 : 243 332 : 341 270 : 303 127 : 139
Blood 23/08/2004 C. orthopsilosis ND
27 HSE Blood 29/08/2002 MG-14 240 : 240 272 : 272 273 : 273 103 : 103
Catheter 20/02/2003 MG-32 243 : 243 299 : 299 264 : 342 129 : 157
Blood 20/02/2003 MG-32 243 : 243 299 : 299 264 : 342 129 : 157
33 HSE Catheter 27/02/2004 MG-11 240 : 240 239 : 239 279 : 312 109 : 109
Blood 27/02/2004 MG-13 240 : 240 239 : 239 294 : 312 109 : 109
35 HSE Blood 20/02/2003 C. orthopsilosis ND
Catheter 28/02/2003 C. orthopsilosis ND
Blood 28/02/2003 C. orthopsilosis ND
36 HSE Catheter 28/02/2003 MG-34 243 : 243 365 : 365 210 : 306 129 : 129
Blood 28/02/2003 MG-34 243 : 243 365 : 365 210 : 306 129 : 129
39 HSE Catheter 29/09/2005 MG-7 234 : 243 287 : 290 297 : 297 131 : 131
Blood 29/09/2005 MG-8 234 : 243 287 : 296 297 : 297 131 : 131
42 SAM Catheter 06/09/2005 MG-22 240 : 243 332 : 332 270 : 303 127 : 139
Blood 06/09/2005 MG-21 240 : 243 329 : 329 270 : 303 127 : 139
Patients with only bloodstream isolates
1 Blood 13/01/2003 C. orthopsilosis ND
Blood 09/02/2004 C. orthopsilosis ND
4 Blood 09/06/2004 MG-16 240 : 243 000 : 000 273 : 303 127 : 139
Blood 01/07/2004 MG-16 240 : 243 000 : 000 273 : 303 127 : 139
5 Blood 19/12/2002 MG-1 189 : 240 236 : 236 315 : 315 165 : 167
9 Blood 05/05/2004 C. orthopsilosis ND
Blood 06/05/2004 C. orthopsilosis ND
15 Blood 01/02/2006 MG-23 240 : 243 332 : 341 270 : 303 127 : 139
29 Blood 28/02/2003 MG-20 240 : 243 269 : 302 270 : 303 127 : 127
Blood 12/05/2003 MG-26 243 : 243 236 : 236 273 : 291 131 : 131
44 Blood 29/12/2003 MG-29 243 : 243 251 : 251 252 : 252 145 : 161
Blood 30/12/2003 MG-29 243 : 243 251 : 251 252 : 252 145 : 161
Blood 13/01/2003 MG-29 243 : 243 251 : 251 252 : 252 145 : 161
MG, multilocus genotype; all1, allele 1; all2, allele 2; ND, not determined.
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Coefficient
0.00 0.21 0.42 0.63 0.84
 001HSEb05 
 002HSEb05 
 013HSEc06 
 057HSEb06 
 058HSEb06 
 023HSEc14 
 098HSEb11 
 029SAMb21 
 032SAMb30 
 100HSEb38 
 038HUPb00 
 054HSEb27 
 055HSEb27 
 082HSEb37 
 012HSEc08 
 019HSEc33 
 076HSEb33 
 021HSEc20 
 003HSEb27 
 014HSEc27 
 099HSEb26 
 088HSEb03 
 005HSEb36 
 015HSEc36 
 044HUPb00 
 027HSEc11 
 024HSEc13 
 093HSEb13 
 042HUPb00 
 043HUPb00 
 035HUPb00 
 007HSEb39 
 008HSEb39 
 026HSEc39 
 020HSEc18 
 085HSEb18 
 063HSEb29 
 081HSEb34 
 ATCC22019 
 048HUPb00 
 049HUPb00 
 050HUPb00 
 051HUPb00 
 077HSEb10 
 069HSEb44 
 073HSEb44 
 070HSEb44 
 095HSEb02 
 009HSEb32 
 031SAMc42 
 010HSEb15 
 011HSEb15 
 025HSEc19 
 022HSEc41 
 030SAMb42 
 083HSEb04 
 084HSEb04 
 061HSEb29 
 080HSEb28 
 039HUPb00 
 040HUPb00 
 041HUPb00 
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Italy, have reported bloodstream incidences for C. para-
psilosis infection of around 60 %, similar to those observed
in Brazil (Delfino et al., 2014). Moreover, the distribution
of C. orthopsilosis and C. metapsilosis as agents of invasive
infections has marked variability. In this study, we report
an overall prevalence of 37 % for C. orthopsilosis and 2 %
for C. metapsilosis among C. parapsilosis sensu lato isolates.
The majority of the patients analysed in this study were
from the HSE and in this hospital the incidence was 28.6 %
for C. orthopsilosis and 4.8 % for C. metapsilosis. These
values are higher than those described in a multi-centre
surveillance study conducted in Brazil between 2003 and
2004 (C. orthopsilosis was 9 % and C. metapsilosis was 3 %;
Gonc¸alves et al., 2010), and those in a Spanish multi-centre
study that reported 8.2 % of C. orthopsilosis and 1.1 % of C.
metapsilosis (Canto´n et al., 2011). Our values are relatively
similar to those recorded in a Spanish study in which 23.5 %
of C. orthopsilosis and 2.1 % of C. metapsilosis were found
(Garcia-Effron et al., 2012). Nevertheless, it is known that
the incidence of C. parapsilosis sensu lato infections varies
according to multiple factors, such as the age and underlying
disease of patients, geographical location of the hospitals
studied and climatic and socio-economic conditions.
A significant finding of this study was the observation that
the same patient can simultaneously have C. parapsilosis
and C. orthopsilosis. Indeed in 9.5 % of patients from the
HSE, both C. parapsilosis and C. orthopsilosis were isolated
and only in one case were the two species isolated on
different dates. To our knowledge, there are few studies
reporting polyfungic infections involving C. parapsilosis
sensu lato species, and none from systemic infections. It
has previously been reported that in superficial infections,
7.5 % those that identified C. parapsilosis complex
species were polyfungal (Feng et al., 2012). However, all
combined C. parapsilosis and C. albicans with Candida
tropicalis or Candida guilliermondii. A previous study
reported two cases of polyfungal infections (C. albicans and
Candida glabrata) in 20 hospitalized patients with catheter-
related candidaemia; however, none of the C. parapsilosis
complex species was involved in polyfungal infections
(Escribano et al., 2014). It has been reported that
polymicrobial BSIs are strongly associated with increased
mortality (Kim et al., 2013). Although there is no study to
date regarding the survival of patients infected with C.
parapsilosis and C. orthopsilosis, the identification of BSI
due to more than one species is of extreme importance.
C. parapsilosis is notorious for the ability to form biofilms
on catheters and other implanted devices (Tumbarello
et al., 2007), more so than the closely related species C.
orthopsilosis and C. metapsilosis (Lattif et al., 2010). This
may explain why in all cases of polyfungal infection the
species identified in the catheter was C. parapsilosis and
never C. orthopsilosis. This was not due to the fact that C.
orthopsilosis was not able to form biolfim, because when C.
orthopsilosis was the only species present, in both blood
culture and catheter, biofilm was identified in the catheter.
This highlights the fact that the species identified in the
catheter is not always that responsible for the BSI. In the
last decade, antifungal susceptibility among C. parapsilosis
sensu lato strains has been considered a matter of concern
worldwide. The identification of one species in the catheter
and another in the bloodstream gives a different perspect-
ive on the evaluation and use of antifungals. This may have
been the case for our patient 11 that showed multiple BSIs
due to C. orthopsilosis and C. parapsilosis, but the catheter
was initially colonized with C. parapsilosis.
In the case where multiple isolates from the same patient
were recovered, we observed that 80 % of C. parapsilosis
bloodstream/catheter pairs showed similar strains (ident-
ical and microvariants strains), indicating a high pro-
bability that the C. parapsilosis strain observed in
the catheter will also be present in the blood culture.
The occurrence of genetic changes in a strain has been
described in catheter-colonizing isolates rather than in
blood isolates, for C. parapsilosis (Romeo et al., 2013) as
well as for C. albicans (Shin et al., 2004). However,
regardless of their origin (blood or catheter), there was a
statistically significant correlation between the identity of
the isolate and the date of collection (P50.0179). In
samples that were collected less than 1 month apart the
isolates were genetically related (identical or micro-
variants), while samples collected at more than 3 months9
interval were genetically distinct. These observations
suggest that C. parapsilosis BSI strains are mainly acquired
from the environment. The identification in this study
of genetically related isolates, persistently isolated from
BSI occurring in different patients in the same hospital,
sometimes over several years, further reinforces the
environmental acquisition of these infections. The temporal
persistence of single C. parapsilosis strains over long periods
of time in the same hospital or ward has been described in
other studies, and was also associated with outbreaks
(A´smundsdo´ttir et al., 2008; Romeo et al., 2013; Viviani
et al., 2006).
In conclusion, taking all our results together, five main
scenarios for C. parapsilosis fungaemia were identified in
this study: (i) monofungal infections due to all three species
of the complex; (ii) polyfungal, always including C.
parapsilosis; (iii) maintenance of the C. parapsilosis infecting
strain when collection dates are less than three months apart;
Fig. 1. Dendrogram showing relationships among 61 Candida parapsilosis isolates based on multilocus microsatellite
genotypes. Dashed boxes represent strains from different patients sharing the same multilocus genotypes, and triangles
represent microvariant strains from different patients. The isolates are represented by a code that includes the isolate number
(000–100), followed by the hospital of origin (HSE, HUP or SAM), by the letter b (for blood) or c (for catheter), and finally the
patient number (01–44; 00 denotes no information available).
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(iv) replacement of the C. parapsilosis infecting strain when
collection dates are more than three months apart; and (v)
micro-variation in the pair bloodstream/catheter C. para-
psilosis strains.
Although the detection of BSIs with C. parapsilosis should
include alerts regarding security breaks in catheter care and
infection control procedures, as previously reported, the
identification of polyfungal infections and their conse-
quences for treatment should also be considered an alert.
The observation that strains can remain in the hospital
environment for years is also an alerts for the possible
existence of specific reservoirs and reinforces the need for
accurate genotyping tools, such as the microsatellite
markers used, for both elucidating epidemiological asso-
ciations and the detection of outbreaks.
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